ArticleFrontiers in endocrinology2026
Associations of derived inflammatory, lipid, and anthropometric indices with CT-detected pulmonary nodules: a hospital-based cross-sectional study with explainable machine learning.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pulmonary nodules are frequently detected during routine health-examination chest computed tomography (CT). From a systems-endocrinology perspective, routinely available indices integrating adiposity distribution, lipid metabolism, immune-cell balance, and low-grade inflammation may characterize cross-organ metabolic-inflammatory phenotypes, but their associations with CT-detected pulmonary nodules remain uncertain. Methods: This hospital-based cross-sectional study included 1,072 adults undergoing routine health examinations at the Second Affiliated Hospital of Shandong First Medical University from 2024 to 2025. The primary outcome was any CT-detected pulmonary nodule; the secondary outcome was an institutional Lung-RADS category ≥3. Right-skewed indices were natural-log transformed before standardization. We applied multivariable logistic regression, Benjamini-Hochberg false-discovery-rate (FDR) correction, a reduced non-redundant representative-index model, restricted cubic splines, repeated nested cross-validation, and machine-learning models with SHAP explanations computed only for held-out observations. Results: CT-detected pulmonary nodules were present in 381 participants (35.54%), and 109 participants (10.17%) had Lung-RADS category ≥3. In the mutually adjusted representative-index model, AIP (OR, 1.38; 95% CI, 1.16-1.64; q = 0.003) and SIRI (OR, 1.37; 95% CI, 1.14-1.64; q = 0.004) were associated with any pulmonary nodule. For the exploratory secondary Lung-RADS category ≥3 outcome (109 events; 6.41 events per model parameter), SIRI was associated with Lung-RADS category ≥3 (OR, 1.48; 95% CI, 1.15-1.91; q = 0.008), but this low-EPV estimate should be interpreted cautiously. In exploratory single-index analyses, several lipid-adiposity and monocyte-related indices remained significant after FDR correction. The basic risk model achieved a cross-validated AUC of 0.76; the derived-index model achieved an AUC of 0.77, without a statistically significant AUC increment (difference, 0.01; P = 0.100). Conclusions: AIP and SIRI were independently associated with CT-detected pulmonary nodules. An exploratory association between SIRI and Lung-RADS category ≥3 was also observed; however, the limited number of events and EPV of 6.41 require cautious interpretation and independent validation. These cross-sectional findings describe an exploratory metabolic-inflammatory phenotype rather than a causal mechanism or clinically ready diagnostic tool. Multicenter longitudinal validation with standardized radiological characterization is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.